Salminen U S
Department of Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Finland.
Eur J Cardiothorac Surg. 1990;4(1):15-8. doi: 10.1016/1010-7940(90)90234-q.
Seventy-seven pulmonary hamartomas were operated upon during a 21-year period (1966-1986); 43 (55.8%) patients were male and 34 (44.2%), female. Thoracotomy was carried out: in all 53 enucleations, 18 wedge resections, 5 lobectomies, and 1 apico-basal segmentectomy were performed. The size of the tumours varied in diameter between 1 cm and 8 cm (mean 2.27 cm) and 23 (29.9%) of patients had previous, concomitant or subsequent pulmonary or pleural disease. Operative mortality was nil. There were 19 postoperative complications in 18 patients. All 77 patients were called for a follow-up examination 6 months to 20 years after operation (mean 8.1 years). Eleven had died, 15 answered with a letter and 39 came to control examination. Thirteen patients did not respond to the questionnaire but were still alive according to the national statistics. One patient developed postoperative lung cancer of which he died 8 years after operation. The others are doing well. Although benign in nature, the only therapy for primary hamartoma is operative removal of the tumour.
在1966年至1986年的21年期间,对77例肺错构瘤患者实施了手术;其中男性43例(55.8%),女性34例(44.2%)。均进行了开胸手术:共实施53例肿瘤摘除术、18例楔形切除术、5例肺叶切除术和1例肺尖 - 基底段切除术。肿瘤直径在1厘米至8厘米之间(平均2.27厘米),23例(29.9%)患者曾患有、同时患有或后来出现肺部或胸膜疾病。手术死亡率为零。18例患者出现19例术后并发症。对所有77例患者在术后6个月至20年(平均8.1年)进行了随访检查。11例患者死亡,15例通过信件回复,39例前来接受复查。13例患者未对问卷作出回应,但根据国家统计数据仍存活。1例患者术后发生肺癌,术后8年死亡。其他患者情况良好。尽管肺错构瘤本质上是良性的,但原发性错构瘤的唯一治疗方法是手术切除肿瘤。